The private shareholders of Pharmaline have sold 55% of their share capital to Gilde Healthcare Partners for an undisclosed consideration.
Pharmaline is specialized in the semi-industrial manufacturing of unregistered pharmacy preparation products. Pharmaline's facilities and production processes are structured to comply with the guidelines of the Dutch Health Care Inspectorate and the Good Manufacturing Practice guidelines, which have been mandatory for a pharmacy preparation production company since 2007. Pharmaline services the Dutch intramural (hospital pharmacies) and extramural (public pharmacies and general practitioner’s pharmacies) pharmacy markets.
Gilde Healthcare Partners is a European venture capital and growth capital firm. The funds focus on companies engaged in the development of novel therapeutics, diagnostics, medical devices and healthcare services.
Oaklins' team in the Netherlands acted as advisor to the seller in this transaction.
© 2019 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.